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Functional  specialization  of cells  is  manifest,  among  other  things,  by  the 
presence  in  the  cell  membrane  of molecules  with  distinct  functions.  These 
molecules may, in some instances, be detected by antibodies and, in this case, are 
termed differentiation antigens.  In both man and mouse the progressive differ- 
entiation of T  cells into functionally discrete sets can be followed with antibodies 
recognizing  distinctive  displays  of differentiation  antigens  (1-3).  In  man,  the 
differentiation  of T  cells from bone marrrow  precursors,  through  the thymus 
and  on  to  peripheral  T  cells,  can  be  enumerated  with  murine  monoclonal 
antibodies, such as OKT1,  3, 4, 6, 8,  10, and  1 1 (4-6).  It is presumed that the 
controlled  expression  or  de-expression  of the  molecules  recognized  by these 
antibodies is a  manifestation  of altering  gene programs  during  differentiation. 
Prothymocytes are a cell type defined by their commitment to T  cell differentia- 
tion,  and  these cells can  be induced  in  vitro and  in  vivo by thymopoietin and 
other inducing agents to express cell surface antigens characteristic of thymocytes 
(7). Although it has not been proven formally that the newly expressed antigens 
are synthesized de novo, this display of differentiation antigens following induc- 
tion requires energy and both RNA transcription and translation  (8). 
Another  class of cell  surface antigens,  termed activation  antigens,  delineate 
the  state  of activation  of mature  T  cells  rather  than  functional  subdivisions. 
These  include  the  antigens  recognized  by  the  monoclonal  antibody  OKIal, 
which  has  been  found  to  represent  a  nonpolymorphic  epitope on  a  molecule 
corresponding to a product of the immune-associated region (9); OKT9, which 
is a transferrin  binding glycoprotein (10); and OKT10, the function of which is 
not yet known (1 1). These antigens are minimally represented on resting periph- 
eral  T  cells although  the  antigens  recognized  by OKIal  and  OKTI0  are  ex- 
pressed on resting cells of other lineages (12); all three antigens are displayed on 
T  cells either following in vitro activation or in vivo during the course of certain 
diseases associated with T  cell activation (10,  13-17). 
In the course of examining the coexpression of two surface antigens on resting 
peripheral  T  cells, using double staining  (indirect  and  direct) with  two mono- 
clonal antibodies, we unexpectedly found high levels of certain antigens typically 
associated with  T  cell activation.  Careful analysis of our methods convinced us 
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that this surprising observation was due to actual expression of these "activation 
antigens" on resting cells and not to a more trivial technical explanation. Appar- 
ently, cell membrane perturbation triggered by cross-linking of the first antibody 
caused the expression of the activation antigens, suggesting that these molecules 
already existed in the cells and  that  the expression of "activation" antigens  on 
"resting" cells did not require their de novo synthesis but rather was related to 
their orientation in the membrane. 
Materials and Methods 
Monoclonal Antibodies.  The derivations of hybridomas producing the monoclonal an- 
tibodies designated OKT1, OKT3, OKT4, OKT6, OKT8, OKT9, OKT10, OKT11, and 
OKIal  have been previously described as have their staining patterns on peripheral T 
cells and thymocytes (4, 9-11, 18-21). Monocional antibody W6/32 reactive with a HLA- 
A,B,C,  framework antigen  was  purchased  from  Pel-Freeze Biologicals (Rogers,  AR). 
Monoclonal antibody 42/6, reactive with the transferrin binding site of the transferrin 
receptor (22), was generously provided by Dr. Ian Trowbridge, Salk Institute. Monocional 
antibody anti-Tac which reacts with the interleukin-2 (IL-2) binding site (23) was a gift of 
Dr. Thomas Waldmann, National Institutes of Health. 
Source of Cells.  Human peripheral blood mononuclear cells were isolated from healthy 
volunteer donors  by  Ficoll-Hypaque density  gradient  centrifugation (Pharmacia  Fine 
Chemicals, Piscataway, N  J). T  cells were obtained by rosetting the mononuclear cells into 
erythrocyte rosette-positive (E+)  ~ and erythrocyte rosette-negative (E-) populations with 
sheep erythrocytes (SRBC).  The  E  ÷ population  was  ~95%  OKT3+ll ÷.  Fractionated 
populations were stored overnight at 4°C in RPMI  1640 containing 20% fetal calf serum 
(Grand  Island  Biological  Co.,  Grand  Island,  NY).  Thymocytes were  obtained  from 
children 3 mo to 6 yr of age undergoing corrective cardiac surgery. Fragments of thymus 
were placed in ice cold RPMI  1640 at the time of removal, shipped on ice and processed 
the same day. 
T  Cell and  Thymocyte  Membrane Perturbation.  To determine the effect of T  cell mem- 
brane perturbation on activation antigen expression, we used a panel of three fluorescein- 
ated monoclonai antibodies, OKIal, OKT9, and OKT10, which define T  cell activation 
antigens. Resting peripheral human T cells or single cell suspensions of human thymocytes 
were stained with these antibodies (a) alone; (b) following incubation with OKT3, OKT4, 
or OKT8  (peripheral T  cells)  or OKT6 (thymocytes); or (c) following cross-linking of 
these antibodies by the addition of horse a-mouse IgG (Vector Labs, Burlingame, CA). 
Quantitative expression of OKIal,  OKT9, and  OKT10 was  determined on resting 
peripheral T cells or thymocytes stained with fluorescein isothiocyanate (FITC) conjugated 
monoclonal antibodies, FITC-OKIal, FITC-OKT9, or FITC-OKT10. In brief, 1 ×  106 
T  cells were suspended in  100 t~l of phosphate-buffered saline (PBS) containing 5 ~tg of 
FITC-conjugated monoclonal antibody, 0.01%  sodium azide, and  5%  fetal calf serum 
(FCS).  The cells were then incubated on ice for 30 min and subsequently washed two 
times with PBS and resuspended to 1 ml. Fluorescence analysis was carried out on a model 
50H Cytofluorograf  (Ortho Diagnostic Systems, Inc., Westwood, MA). Data was compiled 
and analyzed by an interfacing 2150 computer (Ortho Diagnostic Systems, Inc.). 
In order to determine whether the binding of the first monoclonal antibody (OKT3, 
OKT4, OKT6, or OKT8) induced expression of activation antigens, cells were preincu- 
bated with either 0.5 #g of OKT3, OKT4, OKT6, or OKT8 monoclonal antibody for 30 
min at 4°C. The cells were washed two times with PBS, resuspended in PBS, and stained 
with FITC-conjugated monoclonal antibody (see above). 
To ascertain  whether  cross-linking  of surface-bound  monoclonal  antibodies  would 
induce expression of activation antigens, the following procedures were carried out.  I  × 
J Abbreviations used in this paper: E  +, erythrocyte rosette-positive; E-, erythrocyte rosette-negative; 
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106 T  cells or thymocytes were incubated in  100 tA of PBS containing 5% FCS, 0.01% 
sodium azide, and  1 ~g of one of the aforementioned monoclonal antibodies.  The cells 
were incubated on ice for 30 rain and washed two times with PBS. The cell pellets were 
resuspended  in  100 ~1 of PBS containing horse a-mouse IgG at a  final dilution of 1:20 
(previously titrated for saturating concentration), and the cells were incubated on ice for 
an additional  30 min before washing with PBS. The cells were then resuspended in  100 
#1 of PBS containing 50 #g of nonfluorescent mouse IgG (Cappel Laboratories, Cochran- 
ville,  PA) added  to saturate  free combining sites  on  the  horse a-mouse IgG.  The cells 
were incubated on ice for 20 rain after which time 5 ~g of fluoresceinated OKIa 1, OKT9, 
or OKT10 antibodies  were added without a  washing step.  Following an additional  20- 
min  incubatioin  period  on  ice,  the  cells  were  washed  and  resuspended  in  1  ml  PBS 
containing 5%  FCS and 0.01%  sodium azide. As an additional control the same experi- 
ments were carried out using, as the first antibody, a monoclonal antibody to HLA-A,B,C 
framework, this representing a surface antigen not restricted to T  cells. 
Saturation of Free Combining Sites on Horse a-Mouse IgG.  Preincubation of lymphocytes 
with OKT3, OKT4, OKT6, or OKT8 followed by horse c~-mouse IgG and a fluorescein- 
ated  monoclonal antibody  necessitated  a  blocking step  to prevent  the  fluoresceinated 
antibody  from binding  to  unoccupied  sites  on  the  horse  a-mouse  IgG molecule.  The 
amount  of nonfluorescent  mouse  IgG  needed  to  fill  these  sites  was  determined  by 
incubating  1 x  106 peripheral  T  cells with  1 ~g of OKT3, OKT4, OKT6, or OKT8 in 
200 ul of PBS for 30 min on ice. The cells were washed twice in PBS containing 5% FCS 
and 0.01% sodium azide.  100 #1 of a  1:20 dilution of horse a-mouse IgG in PBS plus 5% 
FCS were then added to the cell pellet.  The cells were incubated for 30 rain on ice and 
washed twice as described above. The cells were then incubated with increasing concen- 
trations of nonfluorescent mouse IgG (Cappel Laboratories, Cochranville, PA) for 20 rain 
on  ice.  Following this  incubation  and  without any  wash  steps,  5  ~g of fluoresceinated 
mouse IgG (F:P =  5) were added and the incubation was continued for an additional  20 
rain on ice.  The cells  were then  washed three times with  PBS containing 5%  FCS and 
0.01% sodium azide and resuspended to 1 ml. Fluorescence analysis was carried out on a 
model 50H Cytofluorograf interfaced with a 2150 computer system as described above. 
Transferrin Binding.  Binding of transferrin  to intact cells (24) was measured by incu- 
bating  1 ×  l0 s cells per assay in a  total volume of 0.5 ml of RPMI  1640 containing 1% 
bovine  serum  albumin  with  ~SI-labeled  human  transferrin  [labeled  by  chloramine-T 
iodination  (25)]  at  37°C  for  30  rain.  The  incubation  was  stopped  by  chilling  on  ice 
following addition of 1 mi of ice cold PBS and centrifuging at 400 g for 10 rain at 4°C. 
Both the  supernatant  and  the cell pellet  were assayed for radioactivity and percentage 
radioactivity bound to the cells was calculated.  Transferrin  binding was determined  for 
resting T  cells, T  cells on which display of the transferrin receptor had been induced with 
OKT3  plus  horse a-mouse  IgG and,  as positive controls,  OKT9 + Raji  cells  (a  Burkitt 
lymphoma-derived line) and 3-d phytohemagglutinin (PHA)-activated human peripheral 
T  cells. Specificity of ~25I-transferrin binding was confirmed by competition with various 
concentrations of unlabeled transferrin. 
Expression oflnterleukin-2 (IL-2) Receptor.  The IL-2 receptor,  as enumerated  by anti- 
Tac monoclonal antibody, was induced on peripheral  T  cells by incubation with OKT1 
and  horse  a-mouse IgG. As an independent  measure  of IL-2 receptors the capacity of 
these cells to adsorb IL-2 was determined  in parallel  with similar tests on unperturbed 
peripheral T  cells and 3-d PHA-activated T  cells (positive control).  1 ×  104-1 ×  106 cells 
were incubated with a  predetermined  limiting amount of partially purified IL-2 for 1 h 
at 4°C. The cells were then centrifuged at 4°C for 10 min at 400 g and the supernatants 
were  assayed  for  residual  IL-2  activity  by adding  aliquots  to  day  7  PHA-stimulated 
peripheral  blood lymphocytes, with  measurement  of [SH]thymidine incorporation after 
48 h. 
Results  and  Discussion 
We  first  determined  that  the  percentage  of peripheral  T  cells  stained  with 
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TABLE  I 
Membrane Perturbation of Peripheral T Cells with OKT3 Antibody and Horse a- 
Mouse IgG Induces Expression of Activation Antigens Defined by OKIa l, OKT9, 
and OKTIO 
Horse a-  FITC Monoclonal  Percent of fluorescent 
OKT3  mouse  IgG  antibody  Isotype  cells* 
-  -  OKlal  IgG2a  7, 10, 9, 5 
+  -  OKIal  9, 12, 11, 6 
+  +  OKIal  87, 95, 94, 91 
-  -  OKT9  IgGi  5, 4, 4, 4 
+  -  OKT9  15, 12, 12, 11 
+  +  OKT9  85, 93, 94, 95 
-  -  OKT10  IgGl  19, 21, 10, 23 
+  -  OKT10  19, 20, 11, 15 
+  +  OKTI0  58, 61, 64, 59 
-  -  OKT6  lgGl  3, 1, 1, 1 
+  -  OKT6  3, 1, 3, 1 
+  +  OKT6  3, 1, 4, 1 
-  -  OKT4  IgG2b  64, 64, 62, 60 
+  --  OKT4  67, 64, 62, 61 
+  +  OKT4  67, 65, 65, 62 
-  -  OKT8  IgG2a  26, 37, 40, 36 
+  -  OKT8  25, 36, 39, 40 
+  +  OKT8  29, 36, 38, 40 
* Results obtained from four separate experiments with different donors. 
The presence of OKIal + cells (5-10%) probably represents a  minor contamina- 
tion of the T  cells with E- cells,  most of which are OKIal+; OKT9  ÷ T  cells (4- 
5%) probably represent  background staining; and OKT10  ÷ cells (19-23%) can 
be  attributed  to  minor  contamination  by some  E  rosetting cells  that  may  not 
represent classical T  cells (26) and by E- cells, some of which express the OKT 10 
antigen (27). Preincubation of peripheral T  cells with OKT3 had only a  minimal 
effect on OKIal  staining (6-12%), caused a  modest increase in OKT9 staining 
(11-15%),  and  had  no  effect  on  OKT10  staining  (1 1-20%).  Most  strikingly, 
preincubation with OKT3 and horse a-mouse IgG resulted in marked increases 
of both  fluorescent  intensity  and  percentage of cells  stained  with  OKIal  (87- 
95%), OKT9 (85-95%), and OKT10 (58-64%) (Fig.  1 and Table I). 
Similar results  were obtained  using W6/32,  a  monoclonal antibody to  HLA 
framework, as the first antibody. In a representative experiment, comparing the 
percentage cells stained with first antibody alone and first antibody plus horse a- 
mouse  IgG,  OKT6  remained  unchanged  (2%  and  3%  respectively),  whereas 
69OKIal  (4%  and  43%  respectively),  OKT9  (1%  and  70%  respectively),  and 
OKT10 (22%  and  60%  respectively) all  showed increases in  the percentage of 
stained  cells  and  fluorescent  intensity.  This  established  that  the  membrane 
changes leading to display of activation antigens were not uniquely initiated  by 
cross-linking of special T  cell antigens. 
One artifact that could produce data such as ours would be the binding of the 
fluoresceinated monoclonal antibodies to free o~-mouse IgG sites on the horse o~- 
mouse  IgG  bound  to  the  first  antibody  on  the  cell  surface.  We  tested  this MITTLER  ET  AL. 
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FIGURE  l.  Fluorescence  histograms of  the  distribution of activation antigens on  resting 
peripheral T  cells following membrane perturbation by cross-linking with OKT3 and horse a- 
mouse IgG. Cells were treated with: (a) OKT3 +  FITC-OKIal;  (b) OKT3 +  horse a-mouse 
IgG and F1TC-OKIal; (c) OKT3 +  FITC-OKTg; (d) OKT3 + horse a-mouse IgG and FITC- 
OKT9; (e) OKT3 +  FITC-OKT10; (f) OKT3 +  horse a-mouse IgG and FITC-OKT10.  The 
intensity of staining with FITC-OKIa 1, FITC-OKT9, and FITC-OKT 10 increased when the 
cells were pretreated with OKT3 and horse a-mouse IgG. 
possibility by adding varying amounts of unlabeled mouse IgG and, as shown in 
Table  II,  10 #g of unlabeled  mouse IgG  was sufficient to prevent  binding  of 
FITC-mouse IgG; our experiments used 50 ~g of this preparation of mouse IgG, 
a  dose that effectively occupied all the available sites.  Furthermore,  binding of 
FITC-OKT6, which is negative on resting peripheral T  cells, remained negative 
after  coating  the  cells  with  OKT3  and  horse  a-mouse  IgG.  In  addition,  no 
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TABLE II 
Inhibition of Fhwresceinated Mouse lgG Binding to Free Sites on Horse c~-Mouse IgG by 
Nonfluoresceinated Mouse lgG 
Horse anti-mouse  Nonfluoresceinated  FITC mouse  Percent of fluores- 
OKT3  IgG  mouse IgG*  IgG  *  cent cells  0 
+  +  --  +  92, 94 
+  +  5  +  15,11 
+  +  10  +  3,3 
+  +  25  +  3,3 
+  +  50  +  2,  1 
+  +  100  +  1, 2 
+  -  --  +  1,2 
+  FITC a-MIgG  50  -  97, 97 
* ug/10  6 cells. 
5/~g/10  6 cells. 
Individual results from two experiments. 
treatment with OKT3 antibody and horse o~-mouse IgG (Table I). 
Despite these various controls we directed further experiments at identifying 
the newly expressed activation antigens by techniques that were independent of 
antibody  binding,  as  detected  by  flow  cytometry and  immunofluorescence. 
OKT9  recognizes  the  transferrin  receptor,  albeit  at  a  site  distinct  from  the 
transferrin binding site (28),  whereas 42/6  binds in  the region of the binding 
size  in  that  it competes with  ~25I-transferrin in  binding experiments (22).  We 
found that control OKT9 + and 42/6 + cells, Raji cells, and 3-d PHA-activated T 
cells, bound ~25I-transferrin; with 95,000 cpm (100 ng 125I-transferrin) input Raji 
cells bound  15,000 cpm (1,500 cpm in the presence of excess unlabeled trans- 
ferrin) and 3-d PHA cells bound 6,000  cpm (1,400 cpm with excess unlabeled 
transferrin). In contrast, resting peripheral T  cells treated with OKT3 plus horse 
a-mouse IgG, although OKT9 + (see above), did not bind l~I-transferrin and did 
not  bind  42/6  (Fig.  2).  We  conclude  that  although  membrane perturbation 
caused the exposure of some epitopes of the transferrin receptor molecule (as 
detected by OKT9), the actual transferrin receptor site (as detected by 42/6 and 
125I-transferrin) remained unexposed. It is of interest that two apparently normal 
individuals in our laboratories who donate blood were found to periodically have 
a  high  number  of  OKT9 +  peripheral  T  cells  and  these  did  not  bind  ~2~I- 
transferrin. 
The  interleukin-2  (IL-2)  receptor,  recognized by  the  monoclonal  antibody 
anti-Tac  (23),  also  appears  on  T  cells  following activation.  With  membrane 
perturbation  of resting T  cells with  OKT3  plus  horse a-mouse IgG anti-Tac 
binding rose from 5%  to  88%.  The capacity of these cells to adsorb IL-2 was 
similar to that of 3-d PHA-activated cells (Fig.  3) and was markedly increased 
over that of resting T  cells. In this instance it appears that membrane perturba- 
tion of resting T  cells caused the exposure of the IL-2 binding region of this 
activation antigen. 
Our interpretation of these various data was that cross-linking of cell surface 
bound  monoclonal antibody by  horse  a-mouse  IgG  actually induced the  cell 
surface display of the "activation" antigens. Procedures were carried out in the MITTLER  ET  AL.  105 
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FIGURE  2.  Fluorescence  histograms  of peripheral  T  cells treated  with OKT3  +  horse  a- 
mouse lgG and then stained  with  FITC-OKT9  or 42/6,  mon~lonal antibodies to distinct 
epitopes on the transferrin receptor. OKT9 binding alone became positive (61%), whereas the 
epitope recognized by 42/6, which is situated in the region of the transferrin binding site, was 
not expressed (16%). 
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FIGURE 3.  [3H]thymidine uptake  of late  PHA-stimulated  cells after  addition of standard 
aliquots of IL-2 adsorbed by resting T cells, PHA-activated T cells and T cells with membranes 
perturbed by OKT3 plus horse a-mouse IgG. PHA-activated T cells and membrane-perturbed 
resting T  cells adsorbed similar amounts of IL-2; the residual IL-2 activity after adsorption by 
these ceils was far less than that left after adsorption by resting peripheral T  ceils. 
presence of 0.01%  sodium azide at 4°C,  making it unlikely that these antigens 
could have been synthesized de novo during the time of the experiment. It seems 
likely  that  these  antigens  existed  in  or beneath  the  membrane  in  a  form  not 
detectable on the surface by monoclonal antibodies until membrane rearrange- 
ments, induced by the binding of the first monoclonal antibody and the horse a- 
mouse IgG, caused them to be revealed. 
Expression of activation antigens  on cells following membrane  perturbations 
was  restricted  to  those  cells  bearing  antigen  bound  by  the  first  monoclonal 
antibody.  When  OKT4  or OKT8  (reactive  with  ---65% and  35%  of the  cells, 
respectively)  was used to precoat cells,  only the proportion of cells bearing the 
OKT4  or  OKT8  antigen  expressed  the  activation  antigens  after  addition  of 
horse-a mouse IgG (Fig.  4 and Table  III). By contrast, perturbation of the cell 
surface of peripheral T  cells with OKT3 and horse a-mouse IgG had no effect 106  INDUCTION  OF  ACTIVATION  ANTIGENS  ON  RESTING  T  CELLS 
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FIGURE 4.  Fluorescence histograms of OKla I on peripheral E  + cells before and after cross- 
linking of OKT3, OKT4 or OKT8 antigen with their respective antibodies and horse a-mouse 
IgG. Cells treated with: (a) FITC-OKIal; (b) OKT3 +  horse a-mouse IgG and FITC-OKIal; 
(c) OKT4 + horse a-mouse lgG and FITC-OKIal; (d) OKT8 + horse a-mouse IgG and FITC- 
OKIal. OKT3 +  horse a-mouse IgG induced la expression on most cells, whereas OKT4 or 
OKT8 +  horse a-mouse IgG induced la expression only on subsets of T  cells. 
on  the  expression  of OKT6,  OKT4,  or  OKT8  (Table  I),  implying  that  these 
antigens  represent  stable markers  of a  differentiative  stage of the  T  cell, and 
that they are not induced on cells lacking them by simple membrane rearrange- 
ments. Furthermore, display of activation antigens on OKT4 + cells by membrane 
rearrangement  was not accompanied by a similar display on OKT8 + cells in the 
culture, and vice-versa, as determined by double staining (data not shown); thus, 
there was no evidence for extension of these phenomena by extracellular media- 
tors. 
We further studied these phenomena on human thymocytes. In this instance, 
binding of OKIal  or OKT9 was low when cells were preincubated with OKT6 
in the absence of horse a-mouse IgG (6-8% and  9-15% respectively); OKT10 
binding to thymocytes was high as expected (95-97%),  since OKT10 has been 
previously demonstrated  on  thymocytes (11).  When thymocytes were preincu- 
bated  with  OKT6  and  house  a-mouse  IgG,  the  fluorescence  intensity  and 
percentage of cells staining with  FITC-OKIal  (51-68%) and  OKT9 (76-84%) MITTLER  ET  AL.  107 
TABLE  III 
Membrane Perturbation of Peripheral T Cells with OKT4 or OKT8 
Antibodies and Horse a-Mouse IgG Induces Expression of Activation 
Antigens Defined by OKT9 and OKla l 
Horse a-  FITC monoclonal  Percent of fluores- 
mouse IgG  antibody  cent ceils* 
OKT4 
-  -  OKT4  53, 60, 65 
-  -  OKT9  1, 3, 3 
+  -  OKT9  4, 4, 4 
+  +  OKT9  36, 45, 55 
-  -  OKIal  3,  3,  3 
+  -  OKlal  4, 3, 4 
+  +  OKIal  36, 52, 49 
-  -  OKT6  1, 1, 1 
+  -  OKT6  1, 1, 1 
+  +  OKT6  1, 3, 2 
OKT8 
-  -  OKT8  35, 32, 34 
-  -  OKT9  2, 1, 1 
+  -  OKT9  2, 2, 1 
+  +  OKT9  39, 31, 34 
-  -  OKIal  3,  3,  3 
+  -  OKIal  4, 3, 4 
+  +  OKIal  35, 30, 36 
-  -  OKT6  1, 1, 1 
+  -  OKT6  1, 2, 1 
+  +  OKT6  3, 2, 1 
* Results obtained from three separate experiments with different donors. 
was  markedly  increased  (Fig.  5  and  Table  IV),  whereas  staining  with  OKT10 
remained  unchanged (97-98%). 
These results suggest a  novel control mechanism for the display of certain cell 
membrane  molecules; apparently these are present preformed within or beneath 
the cell  membrane  and are exposed  on the cell surface by membrane  perturba- 
tions.  It will  be  important  to test  this  hypothesis  further  by direct  biochemical 
studies  to determine  whether  these  molecules  reside  within  or beneath  the cell 
membrane  of resting T  cells.  It will also be important to determine  whether the 
natural expression of these molecules is simply dependent  on their reorientation 
in the membrane  or whether chemical  modifications involving protein  or sugar 
changes  or  processes  such  as  phosphorylation  or  acetylation  are  necessary  for 
their  expression.  The  presence  of preformed  molecules  within  the  membrane 
could constitute a reservoir for molecules with functions that are required rapidly 
by the cell in response to stimuli altering its basal state.  In general,  the nature of 
these functions is unknown although OKT9  is known to react with the transferrin 
receptor  that  is  needed  for  iron  uptake  in  replicating  cells  (10)  and  anti-Tac 
reacts  with  the  IL-2  receptor  (23).  It  is  interesting  that  antigens  universally 
expressed  on  some cell  types (for example,  the  Ia antigen  on B  cells and  some 
monocytes and  the  OKT10  antigen  on  null  cells  and  thymocytes) fall  into  the 
category of activation antigens on peripheral  T  cells. 108  INDUCTION  OF  ACTIVATION  ANTIGENS  ON  RESTING  T  CELLS 
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FIGURE 5.  Fluorescence histograms of the distribution of activation antigens on thymocytes 
following membrane perturbation by cross-linking with OKT6 and horse a-mouse immuno- 
globulin. Cells were treated with: (a) OKT6 +  FITC-OKIal; (b) OKT6 +  horse a-mouse IgG 
and FITC-OKIal;  (c)  OKT6  +  FITC-OKT9;  (d) OKT6  +  horse a-mouse  IgG and FITC- 
OKT9; (e) OKT6 +  FITC-OKT10; (D OKT6 +  horse a-mouse IgG and FITC-OKT10.  The 
staining intensity of OKIa 1 and OKT9 increased when the cells were treated with OKT6 and 
horse a-mouse IgG before FITC-OKIa]  or FITC-OKT9,  whereas the fluorescence staining 
intensity with OKT 10 was high initially and remained unchanged. 
Many double-staining protocols employ initial indirect immunofluorescence 
(resulting in cross-linking by o~-mouse IgG) followed by direct immunofluores- 
cence; awareness that the first steps may actually induce expression of the antigen 
recognized by the direct reagent is essential for the proper design and interpre- 
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TABLE IV 
Membrane Perturbation of Thymocytes with OKT6 Antibody and Horse a-Mouse IgG 
Induces Expression of Activation Antigens Defined by OKIa l and OKT9 
Horse a-  FITC monoclonal  Percent of fluorescent 
OKT6  mouse IgG  antibody  lsotype  cells* 
-  -  OKIal  6,  3,  4,  3 
+  -  OKIal  IgG,a  8, 7, 7, 6 
+  +  OKIal  62, 63, 51, 68 
-  -  OKT9  4, 4, 4, 5 
+  -  OKT9  IgG,  10, 12, 9, 15 
+  +  OKT9  78, 76, 84, 78 
-  -  OKT10  98, 96, 98, 96 
+  -  OKT10  IgG~  97, 95, 96, 97 
+  +  OKT10  97, 97, 98, 97 
* Results obtained from four separate experiments with different donors. 
Summary 
Three  human  lymphocyte  antigens  recognized  by  monoclonal  antibodies 
OKIal, OKT9, and OKT10  were found to be minimally represented on resting 
peripheral T  cells (all three) and thymocytes (OKIal and OKT9). These antigens, 
which are present  on  "activated" T  cells,  were promptly displayed on  "resting" 
T  cells or thymocytes following cross-linking of surface-bound monoclonal anti- 
body  by  horse  a-mouse  IgG.  These  experiments  suggested  that  membrane 
perturbations  may induce  the  expression  of certain  antigens  that  are normally 
present in an unexpressed form in resting cells. 
We thank Edward Patten for his technical assistance, Steven Gingras for carrying out the 
IL-2 assays, Marilyn Sanders for her help in editing the manuscript, and Nancy Lawery 
for typing the manuscript. 
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